OTC - ACTIVE INGREDIENT SECTION
Active ingredient Tolnaftate 1%
Active ingredient Tolnaftate 1%
Purpose Antifungal
Uses ■for effective treatment of most athlete’s foot, jock itch, and ringworm
■prevents the recurrence of most athlete’s foot with daily use
Warnings
For external use only
Do not use ■ on children under 2 years of age unless directed by a doctor
When using this product ■ avoid contact with the eyes
Stop use and ask a doctor if
■ irritation occurs ■ there is no improvement within 4 weeks for athlete’s foot and ringworm, and within 2 weeks for jock itch
Keep out reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
■for the treatment of athlete’s foot, jock itch, and ringworm
■cleanse the affected area with soap and water and dry throughly
■apply a thin layer of the product over affected area twice daily (morning and night), or as directed by a doctor
■to prevent athlete’s foot
■cleanse the feet with soap and water and dry throughly
■apply a thin layer of the product to the feet once or twice daily (morning and/or night)
■supervise children in the use of this product
■for athlete’s foot
■pay special attention to spaces between the toes ■wear well-fitting, ventilated shoes ■change shoes and socks at least once daily
■for athlete’s foot and ringworm, use daily for 4 weeks. ■for jock itch, use daily for 2 weeks. ■if condition persists longer, consult a doctor ■this product is not effective on the scalp or nails
Inactive ingredients Carboxymethylcellulose sodium, diethyl sebacate, fragrance, glyceryl monostearate, lauromacrogol 400, light mineral oil, polyoxyethylene cetylether, potassium stearate, propylene glycol, simethicone, sodium lauryl sulfate, stearyl alcohol, urea, water, white wax, zinc oxide.
hiveticointcart.jpg
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1236105 | hiVETIC 1 % Topical Ointment | PSN | 7 |
| 199126 | tolnaftate 1 % Topical Ointment | PSN | 7 |
| 1236105 | tolnaftate 0.01 MG/MG Topical Ointment [hiVETIC] | SBD | 7 |
| 199126 | tolnaftate 0.01 MG/MG Topical Ointment | SCD | 7 |
| 1236105 | hiVETIC 0.01 MG/MG Topical Ointment | SY | 7 |
| 1236105 | hiVETIC 1 % Topical Ointment | SY | 7 |
| 199126 | tolnaftate 1 % Topical Ointment | SY | 7 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2d2ef081-4f0c-4669-81e8-32b263669a0a | Product name | 1 | 20230801 |
| af534dc0-c9e5-19a6-693c-e7ad53714660 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49873-056-01 | Hi Vetic | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 49873-056-01 | Hi Vetic | 15 g in 1 TUBE | OINTMENT | 15 | 7 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| tolnaftate | ACTIVE INGREDIENT | 06KB629TKV | 4 | |
| tolnaftate | ACTIVE MOIETY | 06KB629TKV | 4 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | 4 | |
| CETETH-20 | INACTIVE INGREDIENT | I835H2IHHX | 4 | |
| diethyl sebacate | INACTIVE INGREDIENT | I41B9FJK6V | 4 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 4 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 4 | |
| light mineral oil | INACTIVE INGREDIENT | N6K5787QVP | 4 | |
| POLIDOCANOL | INACTIVE INGREDIENT | 0AWH8BFG9A | 4 | |
| potassium stearate | INACTIVE INGREDIENT | 17V812XK50 | 4 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 4 | |
| silicon | INACTIVE INGREDIENT | Z4152N8IUI | 4 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | 4 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 4 | |
| urea | INACTIVE INGREDIENT | 8W8T17847W | 4 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 4 | |
| white wax | INACTIVE INGREDIENT | 7G1J5DA97F | 4 | |
| zinc oxide | INACTIVE INGREDIENT | SOI2LOH54Z | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49873-056 | 49873-056-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | IACT |
| DIETHYL SEBACATE | I41B9FJK6V | IACT |
| POTASSIUM STEARATE | 17V812XK50 | IACT |
| CETETH-20 | I835H2IHHX | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| UREA | 8W8T17847W | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| WHITE WAX | 7G1J5DA97F | IACT |
| STEARYL ALCOHOL | 2KR89I4H1Y | IACT |
| POLIDOCANOL | 0AWH8BFG9A | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SILICON | Z4152N8IUI | IACT |
| TOLNAFTATE | 06KB629TKV | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / TOPICAL | NA | ||
| light mineral oil | LIGHT MINERAL OIL | N6K5787QVP | OINTMENT / TOPICAL | 1335 mg | ||
| sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / TOPICAL | NA | ||
| diethyl sebacate | DIETHYL SEBACATE | I41B9FJK6V | SOLUTION / TOPICAL | 24 %w/w | ||
| light mineral oil | LIGHT MINERAL OIL | N6K5787QVP | OINTMENT / TOPICAL | 1335 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | LOTION / TOPICAL | 2 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | LOTION / TOPICAL | NA | ||
| diethyl sebacate | DIETHYL SEBACATE | I41B9FJK6V | SOLUTION / TOPICAL | 24 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYSTEM / TOPICAL | 1680 mg | ||
| diethyl sebacate | DIETHYL SEBACATE | I41B9FJK6V | LOTION / TOPICAL | 212 mg | ||
| urea | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | SOLUTION / TOPICAL | 2 %w/w | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | SOLUTION / TOPICAL | 2 %w/w | ||
| urea | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | CREAM / TOPICAL | 429 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| silicon | SILICON | Z4152N8IUI | CREAM / TOPICAL | 0.4 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| zinc oxide | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| diethyl sebacate | DIETHYL SEBACATE | I41B9FJK6V | LOTION / TOPICAL | 212 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYSTEM / TOPICAL | 1680 mg | ||
| silicon | SILICON | Z4152N8IUI | CREAM / TOPICAL | 0.4 %w/w | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | LOTION / TOPICAL | 2 %w/w | ||
| sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| zinc oxide | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | CREAM / TOPICAL | 429 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | LOTION / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hi Vetic | TOLNAFTATE | Sato Pharmaceutical Co., Ltd. | 2096e241-3ed3-49cd-88c4-71db1fd2934a | 2023-12-06 | Warnings | 49873-056-01 49873-056 49873005601 0bde5831-2b16-2948-e063-6394a90ad473 2096e241-3ed3-49cd-88c4-71db1fd2934a |
Adverse event summaries are temporarily unavailable. Other product information remains available.